Amblyopia market seen reaching $5.95 billion by 2030

The global amblyopia market is forecast to grow from $4.87 billion in 2025 to $5.09 billion in 2026, then climb to $5.95 billion by 2030, according to a new market report. Growth is being driven by rising pediatric vision awareness, broader access to treatment and expanding use of digital and home-based therapies.

Why it matters: - The amblyopia market is expanding as more children are screened and treated for lazy eye, a condition that can lead to lasting vision loss if not addressed early. - Demand is rising for therapies that are easier to use at home and in tele-ophthalmology settings, which can widen access to care. - The report points to growing investment in preventive eye care, digital therapeutics and non-invasive treatment options.

What happened: - The Business Research Company released its Amblyopia Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the market will increase from $4.87 billion in 2025 to $5.09 billion in 2026. - The market is projected to reach $5.95 billion by 2030. - The report is available as a free sample. - The full report is available here.

The details: - The report says the market grew at a 4.6% CAGR in the recent period. - It projects 4.0% CAGR growth through 2030. - Growth in the past period came from higher awareness of pediatric vision disorders, better access to corrective lenses, wider use of eye patch therapy, broader ophthalmology services and earlier use of atropine-based treatment. - Future growth is tied to home-based amblyopia therapies, digital therapeutics, preventive eye care for children, tele-ophthalmology and neuro-visual treatment technologies. - Key trends identified in the report include digital vision therapy platforms, AI-powered diagnostic tools, early childhood vision screening, non-invasive treatments and gamified therapy approaches. - Amblyopia, or lazy eye, is a visual development disorder in which one eye has reduced visual acuity even with corrective lenses. - The condition usually develops in infancy or early childhood when the brain and the affected eye do not coordinate properly. - If untreated, the brain can increasingly favor the stronger eye and weaken the other eye further. - The report says rising ophthalmological disorders are a major growth driver for the market. - Drivers cited include greater screen exposure, aging populations and environmental pollution. - The report notes that amblyopia can contribute to permanent vision loss and reduced depth perception if left untreated. - In January 2024, the Centers for Disease Control and Prevention reported that more than 3.4 million Americans age 40 and older were blind or visually impaired, a figure projected to double by 2030.

Between the lines: - The forecast suggests amblyopia care is shifting from a clinic-only model toward more digital, remote and home-centered treatment. - North America’s lead position reflects established health infrastructure and awareness, while faster growth in Asia-Pacific signals expanding care access and investment. - The report’s emphasis on AI, screening and gamified tools suggests vendors are targeting earlier diagnosis and better treatment adherence.

What's next: - North America is expected to remain the largest market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - More information is available through the company’s social channels and contact points listed in the release.

The bottom line: - Amblyopia is moving from a niche pediatric eye-care category into a broader, tech-enabled market with steady global growth through 2030.